Estradiol Benzoate: Precision Estrogen Receptor Alpha Agonist for Research

Executive Summary: Estradiol Benzoate, supplied by APExBIO (SKU B1941), is a synthetic estradiol analog with high affinity for estrogen receptor alpha (ERα), exhibiting an IC50 range of 22–28 nM in human, murine, and avian models [APExBIO Product Page]. It is insoluble in water, but dissolves efficiently in DMSO (≥12.15 mg/mL) and ethanol (≥9.6 mg/mL), enabling consistent assay integration [Pamidronatedisodium 2023]. The compound is validated through HPLC, MS, and NMR, and is supplied with ≥98% purity. Estradiol Benzoate is intended for research use only, providing a reliable tool for estrogen receptor-mediated signaling studies and hormone receptor binding assays (Vijayan et al., 2021). Short-term solution stability is recommended, with storage at -20°C for maximal integrity.

Biological Rationale

Estradiol Benzoate is a synthetic derivative of 17β-estradiol. It acts as a potent estrogen receptor alpha (ERα) agonist, mimicking endogenous estrogenic activity in cellular and animal models [APExBIO]. Estrogen receptors are critical regulators of reproductive, skeletal, cardiovascular, and neural physiology. ERα activation modulates gene expression patterns involved in cell proliferation and differentiation, making it central to hormone-dependent cancer and endocrinology research [Pamidronatedisodium]. Estradiol Benzoate's well-defined binding profile allows researchers to dissect estrogen receptor-mediated signaling without confounding off-target effects.

Mechanism of Action of Estradiol Benzoate

Estradiol Benzoate binds with high specificity and affinity to ERα, with an IC50 of 22–28 nM under standard competitive ligand binding assay conditions (pH 7.4, 25°C, 50 mM Tris buffer) [APExBIO]. Upon binding, the compound induces a conformational change in the receptor, promoting dimerization and nuclear translocation. Activated ERα complexes associate with estrogen response elements (EREs) on DNA, facilitating transcriptional modulation of target genes [Cox2inhibitor]. Estradiol Benzoate also demonstrates progestogen receptor agonism, enabling cross-talk studies between estrogenic and progestogenic pathways.

Evidence & Benchmarks

• Estradiol Benzoate exhibits high-affinity binding to ERα, with IC50 values of 22–28 nM in human, mouse, and chicken models (APExBIO).
• Validated by HPLC, MS, and NMR, the compound is supplied at ≥98% purity for reproducible research (APExBIO).
• Solubility tests confirm ≥12.15 mg/mL in DMSO and ≥9.6 mg/mL in ethanol at 25°C (APExBIO).
• Estradiol Benzoate is used in hormone receptor binding assays to deconvolute ERα-mediated transcriptional networks (Pamidronatedisodium).
• Structural studies reinforce the specificity of ERα-ligand interactions, supporting mechanistic research in hormone-dependent cancer (Vijayan et al., 2021).

Applications, Limits & Misconceptions

Applications:

• Hormone receptor binding assays for both basic and translational research [Details].
• Dissection of estrogen receptor-mediated signaling pathways in cell culture and animal models [Cox2inhibitor].
• Modeling hormone-dependent cancer progression and therapeutic response [Zaragozicacida].
• Endocrinology research targeting reproductive, metabolic, and neural regulation.

This article extends the mechanistic depth provided in the Cox2inhibitor article by adding current purity and storage parameters. It also clarifies workflow integration steps missing from Pamidronatedisodium.

Common Pitfalls or Misconceptions

• Estradiol Benzoate is not suitable for diagnostic or therapeutic in vivo use in humans; research use only [APExBIO].
• Water insolubility prohibits direct aqueous formulation; always dissolve in DMSO or ethanol before dilution (APExBIO).
• Long-term storage of solutions (>1 week) leads to degradation; prepare fresh aliquots for critical assays.
• Assay interference can occur if solvent concentrations exceed 0.1% (v/v) in biological systems.
• Over-reliance on single-ligand studies may not capture full receptor pathway complexity.

Workflow Integration & Parameters

For optimal experimental integration, dissolve Estradiol Benzoate in DMSO or ethanol at the desired stock concentration, ensuring full dissolution by vortexing at room temperature. Typical working concentrations range from 1 nM to 1 μM for receptor binding and signaling assays. Stocks should be stored at -20°C, shielded from light to prevent hydrolysis and photo-degradation [APExBIO]. Short-term (<7 days) storage of solutions is recommended; avoid repeated freeze-thaw cycles. Quality control is confirmed by batch-specific HPLC, MS, and NMR data. For hormone receptor binding assays, a final solvent concentration ≤0.1% (v/v) is advised to minimize cytotoxicity and assay interference. Shipping is performed on blue ice for temperature stability.

Conclusion & Outlook

Estradiol Benzoate (APExBIO, B1941 kit) is a rigorously validated synthetic estradiol analog, enabling precision interrogation of estrogen receptor alpha pathways in research settings. Its robust purity, reproducible solubility, and validated bioactivity make it a cornerstone for hormone receptor binding assays and advanced endocrinology models. By clarifying application boundaries and providing updated workflow guidance, this dossier supports reliable, high-impact estrogen receptor signaling research. For further mechanistic insights and comparative benchmarks, see this mechanistic review, which the present article extends with current storage and purity data.